On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort. Xie Y, Wu S, Huang Y, Zhang Y, et al. Br J Cancer 2026;135:1649-1656.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie Y, Wu S, Huang Y, Zhang Y, et al. On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort. Br J Cancer 2026;135:1649-1656.
PMID: 42661023